BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3794747)

  • 1. Qualitative abnormalities of choline acetyltransferase in Alzheimer type dementia.
    Koshimura K; Kato T; Tohyama I; Nakamura S; Kameyama M
    J Neurol Sci; 1986 Dec; 76(2-3):143-50. PubMed ID: 3794747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
    Koshimura K; Kato T; Yohyama I; Nakamura S; Kameyama M
    Neurosci Res; 1987 Apr; 4(4):330-6. PubMed ID: 3601249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional difference in the kinetics of choline acetyltransferase in brains of neurologically normal elderly people and those with Alzheimer-type dementia.
    Koshimura K; Nakamura S; Miwa S; Fujiwara M; Kameyama M
    J Neurol Sci; 1988 Apr; 84(2-3):141-6. PubMed ID: 3379442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease.
    Sorbi S; Piacentini S; Amaducci L
    Gerontology; 1987; 33(3-4):197-202. PubMed ID: 3653702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.
    Rossor M; Fahrenkrug J; Emson P; Mountjoy C; Iversen L; Roth M
    Brain Res; 1980 Nov; 201(1):249-53. PubMed ID: 7417838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A post-mortem study of the cholinergic and GABA systems in senile dementia.
    Rossor MN; Garrett NJ; Johnson AL; Mountjoy CQ; Roth M; Iversen LL
    Brain; 1982 Jun; 105(Pt 2):313-30. PubMed ID: 7082992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic enzymes in the spinal cord in Alzheimer-type dementia.
    Yates CM; Simpson J; Gordon A; Christie JE
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):311-5. PubMed ID: 2532018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia.
    Rinne JO; Säkö E; Paljärvi L; Mölsä PK; Rinne UK
    J Neural Transm; 1988; 73(2):121-8. PubMed ID: 3210004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalpol regulates cholinergic nerve system function through effect on choline acetyl-transferase not M receptor affinity.
    Wang JH; Xie H; Zhao TK; Kang B
    Biomed Pharmacother; 2015 Feb; 69():291-6. PubMed ID: 25661372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic binding and choline acetyltransferase in postmortem brains of demented patients.
    Waller SB; Ball MJ; Reynolds MA; London ED
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):528-32. PubMed ID: 3791067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Davies P; Terry RD
    Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease.
    Foster NL; Tamminga CA; O'Donohue TL; Tanimoto K; Bird ED; Chase TN
    Neurosci Lett; 1986 Jan; 63(1):71-5. PubMed ID: 3754039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
    Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1980 Dec; 20(3):373-7. PubMed ID: 6108540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    Lippa CF; Smith TW; Perry E
    J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.
    Sorbi S; Antuono P; Amaducci L
    Ital J Neurol Sci; 1980 Mar; 1(2):75-83. PubMed ID: 7040296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
    Wilcock GK; Esiri MM; Bowen DM; Smith CC
    J Neurol Sci; 1982 Dec; 57(2-3):407-17. PubMed ID: 7161627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
    Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A
    Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia.
    Ichimiya Y; Arai H; Kosaka K; Iizuka R
    Acta Neuropathol; 1986; 70(2):112-6. PubMed ID: 3739621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.
    Armstrong DM; Bruce G; Hersh LB; Terry RD
    Neurosci Lett; 1986 Nov; 71(2):229-34. PubMed ID: 2431362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gamma-Glutamyltransferase: normal cortical levels in Alzheimer disease.
    McGeer EG; Singh EA; McGeer PL
    Alzheimer Dis Assoc Disord; 1987; 1(1):38-42. PubMed ID: 2899437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.